About
Technology
Issues
FAQ
Links
Official Page
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.